Riskpilot← Back to searchSign inGet full accessHAUGSTOGA - GRANHEIM AS
ASActiveOrg 988908320Skjoldveien 8C, 0881 OsloMedical specialists activities · NACE 8622Est. 20050 employees
Revenue 2024
NOK 0
EBITDA margin
—
-114% vs 2023
Equity ratio
21.2%
Financial strength
Net profit 2024
NOK 504K
+2607% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -3K | -114% |
| Net profit | NOK 504K | +2607% |
| Total assets | NOK 3,2M | +58% |
| Equity | NOK 671K | +303% |
| Employees | 0 | — |
Legal name
HAUGSTOGA - GRANHEIM AS
Org number
988908320
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
14. november 2005
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Selskapets virksomhet er investeringer i aksjer og andeler samt annen virksomhet i den forbindelse.
Address
Skjoldveien 8C, 0881 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 30 | 20 | 0 | 50 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 7 | 2 | −26 | 24 | −3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 7 | 2 | −26 | 24 | −3 |
| Net financials | 190 | 392 | 39 | 0 | 650 |
| Profit before tax | 197 | 394 | 12 | 24 | 647 |
| Tax | 42 | 87 | 3 | 5 | 142 |
| Net profit | 156 | 307 | 10 | 19 | 504 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 327 | 721 | 2 048 | 2 011 | 3 170 |
| Equity | 138 | 138 | 148 | 166 | 671 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 189 | 583 | 1 900 | 1 845 | 2 499 |
| Total debt | 189 | 583 | 1 900 | 1 845 | 2 499 |
EBITDA margin
-338700.0%
This company
15.8%
Market median
-2143771% vs market
20202024
Equity ratio
21.2%
This company
38.2%
Market median
-45% vs market
20202024
Return on equity
75.2%
This company
18.4%
Market median
+309% vs market
20202024
Net profit margin
50436500.0%
This company
8.1%
Market median
+622672740% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
3.73×
This company
0.62×
Market median
-502% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KH Chief Executive Officer | Chief Executive Officer | 2005 |
KW Deputy Member | Deputy Member | 2005 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HAUGSTOGA - GRANHEIM AS 
GREFSEN TANNLEGESENTER ASBoard members of HAUGSTOGA - GRANHEIM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Harald Granheim | Chief Executive Officer | 0 companies |
| Kristin Wendelborg Haugstoga | Deputy Member | 0 companies |